Pfeiffer-Palm-Teller syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2871OMIM:261560Q87.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pfeiffer-Palm-Teller syndrome, also known as onychodystrophy with absence of distal phalanges, is an extremely rare genetic condition that primarily affects the nails and the bones at the tips of the fingers and toes. People with this syndrome are typically born with absent or severely underdeveloped nails (a condition called anonychia or onychodystrophy) along with missing or shortened end bones (distal phalanges) of the fingers and toes. The condition was first described in medical literature by Pfeiffer, Palm, and Teller, and only a very small number of families have been reported worldwide. Because this condition mainly affects the hands and feet, most individuals can lead relatively normal lives, though they may experience some difficulties with fine motor tasks such as gripping small objects. The cosmetic appearance of the fingertips and toenails can also be a concern for affected individuals. There is no cure for this syndrome, and treatment is focused on managing symptoms and supporting hand function. Occupational therapy may help improve fine motor skills, and cosmetic options for nails may be discussed with a dermatologist. Genetic counseling is recommended for affected families to understand the chance of passing the condition to future children.

Key symptoms:

Absent or severely underdeveloped fingernailsAbsent or severely underdeveloped toenailsMissing or shortened bones at the tips of fingersMissing or shortened bones at the tips of toesShort fingertipsDifficulty with fine motor tasks like picking up small objectsAbnormal appearance of the ends of fingers and toes

Clinical phenotype terms (9)— hover any for plain English
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pfeiffer-Palm-Teller syndrome.

View clinical trials →

No actively recruiting trials found for Pfeiffer-Palm-Teller syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pfeiffer-Palm-Teller syndrome community →

No specialists are currently listed for Pfeiffer-Palm-Teller syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pfeiffer-Palm-Teller syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pfeiffer-Palm-Teller syndromeForum →

No community posts yet. Be the first to share your experience with Pfeiffer-Palm-Teller syndrome.

Start the conversation →

Latest news about Pfeiffer-Palm-Teller syndrome

No recent news articles for Pfeiffer-Palm-Teller syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific tests can confirm the diagnosis of Pfeiffer-Palm-Teller syndrome?,Is genetic testing available to identify the cause in our family?,What is the chance of passing this condition to future children?,Would occupational therapy help improve hand function?,Are there cosmetic options for the absent nails?,Should we schedule regular follow-up appointments, and how often?,Are there any related conditions we should be screened for?

Common questions about Pfeiffer-Palm-Teller syndrome

What is Pfeiffer-Palm-Teller syndrome?

Pfeiffer-Palm-Teller syndrome, also known as onychodystrophy with absence of distal phalanges, is an extremely rare genetic condition that primarily affects the nails and the bones at the tips of the fingers and toes. People with this syndrome are typically born with absent or severely underdeveloped nails (a condition called anonychia or onychodystrophy) along with missing or shortened end bones (distal phalanges) of the fingers and toes. The condition was first described in medical literature by Pfeiffer, Palm, and Teller, and only a very small number of families have been reported worldwide

How is Pfeiffer-Palm-Teller syndrome inherited?

Pfeiffer-Palm-Teller syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pfeiffer-Palm-Teller syndrome typically begin?

Typical onset of Pfeiffer-Palm-Teller syndrome is neonatal. Age of onset can vary across affected individuals.